DENALI ADVISORS LLC

Position in LLY — ELI LILLY & Co

CIK 1142941 SAN DIEGO, CA

Position in LLY

as of Jun 30, 2026 · filed Aug 10, 2026 Compact

Position Value

$15,493,038

+$6,946,536 QoQ

Shares Held

12,917

+39.0% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

1.59%

of 13F equity value

Holder Rank

#1,021

of 4,605 holders

Holding Since

Sep 2024

8 quarters on record

Voting authority Sole 60% Shared 0% None 40%

Healthcare · as of Jun 30, 2026

DENALI ADVISORS LLC holds $21,250,231 across 5 Drug Manufacturers - General names. LLY ranks #1 (72.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co This page	12,917	$15,493,038
2	NVS	Novartis AG	13,287	$2,082,338
3	GSK	GSK plc	28,680	$1,503,405
4	AZN	Astrazeneca PLC	7,025	$1,332,080
5	JNJ	Johnson & Johnson	3,305	$839,370

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$15,493,038	12,917	+39.0%	Shares	Sole	2026-08-10
2026-03-31	$8,546,502	9,292	+38.3%	Shares	Sole	2026-05-08
2025-12-31	$7,222,924	6,721	-0.8%	Shares	Sole	2026-02-03
2025-09-30	$5,167,036	6,772	-47.0%	Shares	Sole	2025-11-07
2025-06-30	$9,959,275	12,776	-5.5%	Shares	Sole	2025-07-30
2025-03-31	$11,162,999	13,516	-1.3%	Shares	Sole	2025-05-05
2024-12-31	$10,567,136	13,688	-12.0%	Shares	Sole	2025-02-04
2024-09-30	$13,779,024	15,553	—	Shares	Sole	2024-11-13
No filing history on record for this holder in this stock.